Central pontine myelinolysis prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Central pontine myelinolysis}} | {{Central pontine myelinolysis}} | ||
{{CMG}} | {{CMG}} | ||
==Prevention== | ==Prevention== | ||
*Gradual, controlled treatment of low sodium levels may reduce the risk of nerve damage in the pons. | *Gradual, controlled treatment of low sodium levels may reduce the risk of nerve damage in the pons. | ||
| Line 16: | Line 16: | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Needs overview]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 20:53, 3 December 2012
|
Central pontine myelinolysis Microchapters |
|
Differentiating Central pontine myelinolysis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Central pontine myelinolysis prevention On the Web |
|
American Roentgen Ray Society Images of Central pontine myelinolysis prevention |
|
Risk calculators and risk factors for Central pontine myelinolysis prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Prevention
- Gradual, controlled treatment of low sodium levels may reduce the risk of nerve damage in the pons.
- Being aware of how some medications can change sodium levels can prevent these levels from changing too quickly.